Note: Ingredients listed on restricted chemical lists
EC/CAS
459-330-2/406-78-0
Name of the chemical
(1H,1H-Perfluoroethyl)(2H-perfluoroethyl)ether
Concentration
5
General Information
Version
1.2
Revision date
2025-01-13
Product name
Solvex HD Plus
supplier name
Samuel Banner & Co Ltd
Emergency telephone
+44 (0)1270 502891
Icons in SDS
Company Information
company name
Samuel Banner & Co Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
sdsadmin@bannerchemicals.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319, H332, H336, H412
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
May cause drowsiness or dizziness. Harmful if inhaled. Causes serious eye irritation. Harmful to aquatic life with long lasting effects
Hazard pictograms
GHS07
Signal word
Warning
Contains
trans-DICHLOROETHYLENE; 1,1,2,2-Tetrafluoroethyl-2, 2,2-trifluoroethyl ether
Hazard statements
H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H336 - May cause drowsiness or dizziness. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P261 - Avoid breathing vapours, spray. P280 - Wear protective clothing, eye protection, face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P273 - Avoid release to the environment. P308+P313 - IF exposed or concerned: Get medical advice/attention.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (inhal.), Category 4 H332 Acute toxicity (inhalation:dust,mist) Category 4 H332 Serious eye damage/eye irritation, Category 2 H319 Specific target organ toxicity – Single exposure, Category 3, H336 Narcosis Hazardous to the aquatic environment – Chronic Hazard, H412 Category 3 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause drowsiness or dizziness. Harmful if inhaled. Causes serious eye irritation. Harmful to aquatic life with long lasting effects.